Following an inspection earlier this year that yielded a Form 483, Indian generics juggernaut Alembic Pharmaceuticals has ...
Novartis' CEO remains unfazed by the threat of a newly approved oral PCSK9 inhibitor in Merck & Co.’s Lipfendra, doubling ...
Novo Nordisk has accused Eli Lilly of running ad campaigns containing “deliberately false” messages that mislead the public ...
Detailed phase 3 results suggest the two-drug combination of Gilead Sciences’ lenacapavir and Merck & Co.’s islatravir has ...
South Korean contract manufacturer Samsung Biologics hopes to tap into the booming peptide production and weight loss market with plans to buy out Switzerland-based CDMO PolyPeptide for 1.46 billion ...
On paper, it was another strong quarter for Carvykti. Johnson & Johnson reported record sales for the CAR-T therapy, ...
Actress Rebel Wilson pairs GLP-1s and healthy habits to lose weight 'for keeps' in new Noom campaign
The campaign is one of weight loss app Noom's largest brand investment to date and features two TV spots and new in-app ...
After nearly a century of naming its Person of the Year each December, Time is adding another prestigious recognition with help from Johnson & Johnson. J&J and Time are teaming up to honor a ...
Pacira BioSciences, Inc., an innovative biopharmaceutical company, focuses on non-opioid therapies that address a diverse range of musculoskeletal pain needs, including chronic and post-surgery pain.
From Indiana to Iceland, the FDA this week disclosed concerns raised during recent visits to a pair of manufacturing sites ...
In Novo Nordisk and Eli Lilly’s competition to launch their respective GLP-1 obesity pills in the United States, the Danish ...
Antibody-drug conjugates from Kelun-Biotech and Hansoh Pharma, respectively partnered with Merck & Co. and GSK, delivered positive phase 3 readouts in China. AstraZeneca reached out to its spinout, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results